A program to help people with pulmonary fibrosis take better care of themselves
Part of Lungs & breathing clinical trials.
This trial tests if a motivational interviewing program can help people with idiopathic pulmonary fibrosis improve their self-care skills over time. You will be assigned to either the program group or a usual care group, and your self-care will be tracked for 18 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with idiopathic pulmonary fibrosis for at least one year.
- You are 18 years old or older.
- You can give your consent to participate in the study.
- You have a tablet, smartphone, or computer with internet access.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a smartphone app called FORTISKAP™ that reminds you to take your medications versus standard care. The trial includes people with interstitial lung disease (a scarring condition of the lungs), sarcoidosis (an inflammatory condition), or pulmonary hypertension (high blood pressure in the lungs), and aims to see if the app helps people take their medications more reliably.
This Phase 2 study tests whether an oral medication (INS018_055) can help people with idiopathic pulmonary fibrosis (IPF). You may be a fit if your lung function is in a certain range and your condition is stable.
This study uses safe, painless scans (like muscle ultrasound and a body composition test) to track changes in muscle and fat in patients with IPF or PPF who are starting anti-fibrotic medication. The goal is to better understand how these treatments affect your body.
This study tests a learning and self-management program for people with pulmonary fibrosis. It helps you better understand and manage your lung condition.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
Hear when a new Idiopathic Pulmonary Fibrosis (IPF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.